News

There is an urgent need to improve diagnostic abilities and management of borderline personality disorder, despite significant breakthroughs.

Looking at post-mortem brain samples, researchers found that multiple sclerosis is associated with an abundance of bacteria and molecular diversity.

Researchers evaluated the correlation between clinical and laboratory findings to identify biomarkers for a range of chronic spontaneous urticaria criteria including differential diagnosis, activity, duration, patient subgroups allocation, and response to treatment.

An experimental vaccine is showing 100% effectiveness against the Ebola virus, according to results of a trial in Guinea published in The Lancet.

The second of a two-part, year-end review of advances against eczema/dermatitis (AD) focused on treatment and prevention, noting there was little evidence showing "relative efficacy" of common systemic treatments.

Researchers compiled best practices for clinicians diagnosing and treating aquagenic urticaria (AU), a rare, but debilitating form of the skin disorder that leaves patients unable to bathe, sweat, or cry without breaking out in painful wheals.

An end-of-year two-part review highlighted that despite prevalent outcome measures, there is no consensus on the definition of a flare in atopic dermatitis.

During follow-up periods ranging from six months to 10 years, no increase in IOP over time was found in AMD or DME patients who received intravitreal injection of an anti-VEGF agent, no matter how many injections they received.

Electric shocks, hot tea, and cryogenic freeze are just a few of the topics that came up in 2016 during the constant search to better understand and treat rheumatoid arthritis.

Between daily news and conferences around the United States and Europe, it was a busy year in multiple sclerosis research.

While effective for Clostridium difficile (C. difficile) infection in irritable bowel syndrome (IBS) patients, fecal microbiota transplants did not relieve the IBS itself.

Researchers have been studying the potential multiple sclerosis drug ocrelizumab (Ocrevus/Genentech) for years. Results from those studies have been published in the New England Journal of Medicine (NEJM).

In the SAKURA study, a greater proportion of those in the intravitreal sirolimus treatment groups than those in the active control group met the primary endpoint, a vitreous haze score of zero at Month 5 without the use of rescue therapy.

Finding neural stem cells in the brain’s meninges could lead to new therapies for multiple sclerosis patients.

People most at risk of needing adrenaline auto-injectors tend not to know how to use them properly, studies have found. Physicians are blamed for the lapses.

The pros identified included the possibility of EMDs improving adherence, that the devices might help motivate patients through creating a sense of independence and accountability, and that the data generated could help in building a trusting relationship between clinician and patient.

An investigational regimen of glecaprevir and pibrentasvir has proven to perform well in patients with hepatitis C genotypes 1 to 6 without cirrhosis.

In a new study, stroke occurred in 6.6% of the ranibizumab-treated group, compared with 7.0% of the controls matched by sociodemographic factors and comorbidities and 6.7% of the controls matched by sociodemographic factors only. These differences were not statistically significant.

Alemtuzumab was more beneficial to patients with relapsing remitting multiple sclerosis than subcutaneous interferon beta 1a in various measures of preexisting disability.

Most dermatologists in the United Kingdom choose phototherapy first when treating adult patients with recalcitrant moderate-to-severe atopic eczema/dermatitis (AD).

A new study reported no increased incidence of heart disease in patients treated for chronic urticaria, despite prior research highlighting a potential association with other cardiac risk precursors.

The FDA expands indication for a glucose monitoring system to replace finger-stick blood glucose testing for patients at least 2 years old who are being treated for diabetes.

Many off label therapeutic options currently exist for treating Clostridium difficile (C. difficile) infection, but combinations of these choices can develop into viable, approved treatments, according to a recently published product review.

Patients said that it can be difficult to identify opportunities to participate in research, and all groups agreed that a “language gap” exists between researchers and patients.

A retrospective review of patients with bilateral uveitic glaucoma who had filtration surgery in both eyes at different times found that the second surgically treated eye showed greater glaucomatous disc progression than the first.

Listerine doesn't just help provide fresh breath. A new study shows its fighting properties against gonorrhea.

Traces of Clostridium difficile bacteria are occasionally found in the final products of manure compost and can even transfer C. difficile into the food chain.

ASP0892 is an investigational DNA vaccine for the common, potentially fatal allergy.

Studies have shown that HIV increases the risk of confusion and forgetfulness, but new research found that the virus is tied to more serious neurocognitive conditions.